2025 perinatal substance use

PrOUD Program: Program Creation, Evolution, and Lessons Learned

Optimal care of pregnant people with opioid use disorder requires a comprehensive program capable of supporting a pregnant person and family throughout pregnancy and the first year of the infant's life. In this presentation, the speakers will describe the initial development of the PrOUD Program, its evolution over time to its current state, and five-year outcome data.

Register to unlock the course, then click ‘Continue.’ Course materials are also available at the bottom of this page.
Write your awesome label here.

Colleen Allen, MSW

Social Worker
ProHealth Care

Jessica Knipfer, APNP

Nurse Practitioner
Program Coordinator, PrOUD Program
ProHealth Care

Susanne Krasovich, MD

Family Physician
Medical Director, PrOUD Program
Medical Director, Family Medicine Residency Program Clinic
ProHealthCare

Maureen Longeway, MD

Family Physician
Faculty, Family Medicine Residency Program
ProHealth Care

Learning Outcomes

At the conclusion of this activity, participants will be able to:
  • Describe the development of the unique PrOUD Program (formerly MAT4Moms) of integrated MOUD family care.
  • Describe the systemic and educational efforts needed to create and sustain this program, and how the program has evolved over time.
  • Review outcomes, additional successes, and ongoing challenges.


Accreditation Statement

Continuing Medical Education

The Wisconsin Association for Perinatal Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians.

The Wisconsin Association for Perinatal Care (WAPC) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Committee

No one in control of content has any relevant financial relationships with ineligible companies.*

Course Information

This webinar was recorded on September 11, 2025.

The expiration date for this course is October 6, 2028.

*Ineligible companies are those whose primary business is producing, marketing, selling, reselling, or distributing health care products used by or on patients.